Understanding Polycythemia Vera - PowerPoint PPT Presentation

About This Presentation
Title:

Understanding Polycythemia Vera

Description:

Polycythemia vera (PV) is a rare, chronic blood disorder characterized by an overproduction of red blood cells, white blood cells, and platelets in the bone marrow. This overproduction can lead to increased blood volume and viscosity, causing complications such as blood clots, strokes, and heart attacks. PV is one of the myeloproliferative neoplasms, a group of disorders caused by abnormal proliferation of blood cells. – PowerPoint PPT presentation

Number of Views:3
Slides: 11
Provided by: drpawankumarsingh8
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Understanding Polycythemia Vera


1
BEST BMT Dr.Pawan Kumar Singh
Dr Pawan Kumar Singh
Dr Pawan Kumar Singh has the experience of
performing more than 500 bone marrow transplants
(including Autologous /Allogenic /Haplo /MDU )for
both malignant and non-malignant disorders.
2
Content List
Introduction Polycythemia Vera
Symptoms Of PV
Causes Of PV
Treatment Options
3
Introduction
This comprehensive guide delves into Polycythemia
Vera (PV), a rare hematologic condition
characterized by the excessive production of red
blood cells in the bone marrow. Classified under
myeloproliferative neoplasms, PV causes an
overabundance of blood cells, which thickens the
blood and leads to potential complications.
Throughout this exploration, we'll delve into the
intricate details of PV, discussing its symptoms,
causes, diagnostic methods, and treatment
options. Furthermore, we'll underscore the
significance of seeking expert medical
assistance, including the quest for the finest
bone marrow transplant (BMT) Specialist In Delhi.
4
Understanding Polycythemia Vera
Polycythemia Vera originates from a mutation in
the bone marrow's stem cells, leading to the
uncontrolled production of red blood cells. This
overproduction thickens the blood, making it flow
more sluggishly through the body's blood vessels,
increasing the risk of clotting. PV can affect
individuals of any age but is more common in
adults around 60 years of age.
5
Symptoms of Polycythemia Vera
  • Headaches Frequent and severe headaches are a
    common complaint among PV patients.
  • Fatigue Due to the thickened blood, the body's
    organs may not receive adequate oxygen, leading
    to persistent fatigue.
  • Itching Unexplained itching, particularly after
    exposure to warm water, is a common symptom of
    PV.

6
  • Blurred vision The increased viscosity of blood
    can affect blood flow to the eyes, resulting in
    blurred vision.
  • Dizziness or lightheadedness Reduced blood flow
    to the brain can cause dizziness or
    lightheadedness.

7
Causes of Treatment Options
The exact cause of PV remains unknown, although
it is primarily linked to a mutation in the JAK2
gene. This mutation leads to the uncontrolled
production of red blood cells in the bone marrow.
While the specific triggers for this mutation are
unclear, certain risk factors may increase the
likelihood of developing PV, including genetic
predisposition and environmental factors.
8
Diagnosis of Polycythemia Vera
  • Diagnosing PV involves a combination of medical
    history review, physical examination, and
    laboratory tests. Key diagnostic tests include
  • Complete Blood Count (CBC) Elevated red blood
    cell count is a primary indicator of PV.
  • JAK2 Mutation Test This genetic test helps
    identify the JAK2 mutation present in the
    majority of PV patients.
  • Bone Marrow Biopsy A sample of bone marrow is
    examined to confirm the diagnosis and assess the
    extent of cell proliferation.

9
Treatment Options for Polycythemia Vera
  • Phlebotomy This procedure involves removing a
    specific amount of blood to reduce the thickness
    and viscosity of the blood.
  • Medications Prescription medications such as
    hydroxyurea or interferon-alpha may be prescribed
    to suppress the bone marrow's overactivity.
  • Aspirin Therapy Low-dose aspirin is often
    recommended to reduce the risk of blood clots.
  • Biological Therapies In some cases, biological
    therapies such as JAK inhibitors may be used to
    target the underlying genetic mutation

10
Thank
You!
Get In Contact!
Write a Comment
User Comments (0)
About PowerShow.com